In breast cancer cell lines, direct activation of β-AR signaling was shown to enhance the expression of proangiogenic factors, including vascular endothelial growth factor (VEGF) and interleukin (IL)-6 (Madden et al., 2011). This evidence concerns the gene ADRB2 and breast carcinoma.